SCHEMBL2863967

SCHEMBL2863967

COC(=O)c1ccc(F)c(C(=O)c2cccc(F)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.53
MEN1 O00255 5/20 0.53
LMNA P02545 2/20 0.53
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
MRGPRX4 Q96LA9 1/20 0.50
POLB P06746 1/20 0.50
CTDSP1 Q9GZU7 1/20 0.50
MAPT P10636 1/20 0.50
ALDH1A1 P00352 7/20 0.48
KDM4E B2RXH2 1/20 0.48
ERN1 O75460 1/20 0.45
PKM P14618 1/20 0.45
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ESR1 P03372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17070601 0.84 KMT2A (0.69) KMT2AMEN1LMNANPC1RAB9A
SCHEMBL29570653 0.84 KMT2A (0.69) KMT2AMEN1LMNANPC1RAB9A
SCHEMBL1056526 0.84 KMT2A (0.69) KMT2AMEN1LMNANPC1RAB9A
Hydrochloric Acid SCHEMBL30779154 0.83 KMT2A (0.67) KMT2AMEN1LMNANPC1RAB9A
SCHEMBL2860775 0.82 KDM4E (0.51) KMT2AMEN1KDM4ECES2CES1
SCHEMBL1401556 0.80 KDM4E (0.58) KMT2AMEN1LMNASMN1; SMN2POLB
SCHEMBL27558516 0.79 ERN1 (0.49) KMT2AMEN1LMNANPC1RAB9A
SCHEMBL8807005 0.79 NPC1 (0.56) KMT2AMEN1LMNANPC1RAB9A
SCHEMBL2865317 0.78 CES2 (0.44) KMT2AMEN1LMNANPC1RAB9A
SCHEMBL2421211 0.77 KDM4E (0.56) KMT2AMEN1LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KMT2A 2212/4885MEN1 3782/4885LMNA 1893/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 KMT2A 2834/4885MEN1 4417/4885LMNA 1548/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KMT2A 2212/4885MEN1 3782/4885LMNA 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.